Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Cytotherapy
|
February 27, 2010
Large-scale Ficoll gradient separations using a commercially available, effectively closed, system
William E Janssen, Albert Ribickas, Laura V Meyer, et al.
Expert Opinion on Biological Therapy
|
April 28, 2010
INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect
Alberto A Chiappori, Hatem Soliman, William E Janssen, et al.
British Journal of Haematology
|
June 26, 2003
Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation
Paul Fallon, Tracy Gentry, Andrew E Balber, et al.
American Journal of Hematology
|
June 8, 2012
Retrospective comparison of filgrastim plus plerixafor to other regimens for remobilization after primary mobilization failure: clinical and economic outcomes
Janelle B Perkins, Jamie F Shapiro, Ryan N Bookout, et al.
Cytotherapy
|
November 16, 2010
Cell therapy medical tourism: time for action
Kurt C Gunter, Arthur L Caplan, Chris Mason, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2019
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia
Rosa Nguyen, Huiyun Wu, Stanley Pounds, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2020
Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial
Rosa Nguyen, Natasha Sahr, April Sykes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 24, 2017
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
Sara M Federico, M Beth McCarville, Barry L Shulkin, et al.
Haematologica
|
June 13, 2012
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation
Joseph Pidala, Jongphil Kim, Heather Jim, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Cytotherapy
|
February 27, 2010
Large-scale Ficoll gradient separations using a commercially available, effectively closed, system
William E Janssen, Albert Ribickas, Laura V Meyer, et al.
Expert Opinion on Biological Therapy
|
April 28, 2010
INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect
Alberto A Chiappori, Hatem Soliman, William E Janssen, et al.
British Journal of Haematology
|
June 26, 2003
Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation
Paul Fallon, Tracy Gentry, Andrew E Balber, et al.
American Journal of Hematology
|
June 8, 2012
Retrospective comparison of filgrastim plus plerixafor to other regimens for remobilization after primary mobilization failure: clinical and economic outcomes
Janelle B Perkins, Jamie F Shapiro, Ryan N Bookout, et al.
Cytotherapy
|
November 16, 2010
Cell therapy medical tourism: time for action
Kurt C Gunter, Arthur L Caplan, Chris Mason, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2019
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia
Rosa Nguyen, Huiyun Wu, Stanley Pounds, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2020
Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial
Rosa Nguyen, Natasha Sahr, April Sykes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 24, 2017
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
Sara M Federico, M Beth McCarville, Barry L Shulkin, et al.
Haematologica
|
June 13, 2012
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation
Joseph Pidala, Jongphil Kim, Heather Jim, et al.
Page
of 1